Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Psychopharmacology (Berl). 2013 May 28;230(2):10.1007/s00213-013-3145-2. doi: 10.1007/s00213-013-3145-2

Fig. 5.

Fig. 5

Concentrations of dFBr in blood and cerebrospinal fluid after subcutaneous administration in rats (n = 4). The time points for collecting blood and cerebrospinal fluid samples corresponded to the start and end times of the self-administration test sessions.